THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer

HANDLE Open Access
  • Omatsu, Mayuki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Nakanishi, Yuki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Iwane, Kosuke
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Aoyama, Naoki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Duran, Angeles
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Muta, Yu
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine; Present address: Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Martinez-Ordoñez, Anxo
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Han, Qixiu
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Agatsuma, Nobukazu
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Mizukoshi, Kenta
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Kawai, Munenori
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Yamakawa, Go
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Namikawa, Mio
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Hamada, Kensuke
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Fukunaga, Yuichi
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine; Cancer Research Unit, Sumitomo Pharma Co., Ltd
  • Utsumi, Takahiro
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Sono, Makoto
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Masuda, Tomonori
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Hata, Akitaka
    Department of Dermatology, Kyoto University Graduate School of Medicine
  • Araki, Osamu
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Nagao, Munemasa
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Yoshikawa, Takaaki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Ogawa, Satoshi
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Hiramatsu, Yukiko
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Tsuda, Motoyuki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Maruno, Takahisa
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Kogame, Toshiaki
    Department of Dermatology, Kyoto University Graduate School of Medicine
  • Kasashima, Hiroaki
    Department of Gastroenterological Surgery, Osaka Metropolitan University
  • Kakiuchi, Nobuyuki
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine; The Hakubi Center for Advanced Research, Kyoto University
  • Nakagawa, Masahiro M.
    Department of Pathology and Tumor Biology, Kyoto University
  • Kawada, Kenji
    Department of Gastrointestinal Surgery, Kyoto University, Graduate School of Medicine
  • Yashiro, Masakazu
    Department of Gastroenterological Surgery, Osaka Metropolitan University
  • Maeda, Kiyoshi
    Department of Gastroenterological Surgery, Osaka Metropolitan University
  • Saito, Yasuyuki
    Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine
  • Matozaki, Takashi
    Division of Molecular and Cellular Signaling, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine; Division of Biosignal Regulation, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine
  • Fukuda, Akihisa
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine
  • Kabashima, Kenji
    Department of Dermatology, Kyoto University Graduate School of Medicine
  • Obama, Kazutaka
    Department of Gastrointestinal Surgery, Kyoto University, Graduate School of Medicine
  • Ogawa, Seishi
    Department of Pathology and Tumor Biology, Kyoto University
  • Sheibani, Nader
    Department of Ophthalmology and Visual Sciences, University of Wisconsin-, Madison
  • Diaz-Meco, Maria T.
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Moscat, Jorge
    Department of Pathology and Laboratory Medicine, Weill Cornell Medicine
  • Seno, Hiroshi
    Department of Gastroenterology and Hepatology, Kyoto University Graduate School of Medicine

Abstract

Mesenchymal activation, characterized by dense stromal infiltration of immune and mesenchymal cells, fuels the aggressiveness of colorectal cancers (CRC), driving progression and metastasis. Targetable molecules in the tumor microenvironment (TME) need to be identified to improve the outcome in CRC patients with this aggressive phenotype. This study reports a positive link between high thrombospondin-1 (THBS1) expression and mesenchymal characteristics, immunosuppression, and unfavorable CRC prognosis. Bone marrow-derived monocyte-like cells recruited by CXCL12 are the primary source of THBS1, which contributes to the development of metastasis by inducing cytotoxic T-cell exhaustion and impairing vascularization. Furthermore, in orthotopically generated CRC models in male mice, THBS1 loss in the TME renders tumors partially sensitive to immune checkpoint inhibitors and anti-cancer drugs. Our study establishes THBS1 as a potential biomarker for identifying mesenchymal CRC and as a critical suppressor of antitumor immunity that contributes to the progression of this malignancy with a poor prognosis.

Journal

Related Projects

See more

Details 詳細情報について

  • CRID
    1050297969507605632
  • ISSN
    20411723
  • HANDLE
    2433/285783
  • Text Lang
    en
  • Article Type
    journal article
  • Data Source
    • IRDB

Report a problem

Back to top